<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: tumor response</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>CT imaging taken post avastin may predict survival in patients with metastatic colorectal cancer</title>
   	 <description>Using routine computed tomography (CT) imaging to analyze form and structural changes to colorectal liver metastasis after bevacizumab and chemotherapy may predict overall survival, according to research from The University of Texas M. D. Anderson Cancer Center.</description>
     <link>http://www.physorg.com/news178909616.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 01 Dec 2009 17:07:38 EST</pubDate>
	 <guid isPermaLink="false">news178909616</guid>
</item>
<item>
     <title>Angiogenesis inhibitor improves brain tumor survival by reducing edema</title>
   	 <description>The beneficial effects of anti-angiogenesis drugs in the treatment of the deadly brain tumors called glioblastomas appear to result primarily from reduction of edema - the swelling of brain tissue - and not from any direct anti-tumor effect, according to a study from Massachusetts General Hospital (MGH) researchers.  Their report, to be published in the Journal of Clinical Oncology and receiving early online release, describes how treatment with the experimental drug cediranib reduced edema and improved survival in three mouse models of glioblastoma.</description>
     <link>http://www.physorg.com/news157616326.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 30 Mar 2009 07:19:27 EST</pubDate>
	 <guid isPermaLink="false">news157616326</guid>
</item>
<item>
     <title>Glitches in DNA repair genes predict prognosis in pancreatic cancer</title>
   	 <description>Variations in mismatch repair genes can help predict treatment response and prognosis in patients with pancreatic cancer, according to research from The University of Texas M. D. Anderson Cancer Center presented today in advance of the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium. </description>
     <link>http://www.physorg.com/news151141502.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 14 Jan 2009 07:45:02 EST</pubDate>
	 <guid isPermaLink="false">news151141502</guid>
</item>


</channel>
</rss>

